Flot.bio x Philip Hemme cover image

Otello Stampacchia, Omega Funds šŸ‡®šŸ‡¹ | M&A, Boston & Pasta | E18

Flot.bio x Philip Hemme

00:00

Navigating the Pharma Landscape

This chapter explores the challenges facing the pharmaceutical industry, especially the shift towards smaller biotech firms for pipeline development amid a scarcity of large-scale acquisitions. It highlights the significant increase in clinical trials conducted by these smaller entities and examines the financial dynamics of recent acquisitions, emphasizing strategic motivations behind major deals. The discussion also addresses the implications of drug pricing and access within the U.S. healthcare system, comparing it to European models, and advocating for a better understanding of the industry's complex landscape.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app